Related Experiment Videos
Cybernetic mechanisms of the effects of pharmacological agents on variables subject to negative feedback control
Proceedings of the Western Pharmacology Society
|January 1, 1983
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
Research in social & administrative pharmacy : RSAP·2006
Decrease of cyclin D1 in the human lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin.
Lung cancer (Amsterdam, Netherlands)·2001
[Integrins and integrin-associated molecules: targets for the development of antimetastatic therapies].
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·1999
Ageing, health and medication consumption in a sample of academic employees at a Mexican university.
Proceedings of the Western Pharmacology Society·2012
Treatment with LA-419 prevents monocrotaline-induced pulmonary hypertension and lung injury in the rat.
Proceedings of the Western Pharmacology Society·2012
Valproic acid modulates brain plasticity through epigenetic chromatin remodeling in the blind rat: implications for human sight recovery.
Proceedings of the Western Pharmacology Society·2012
Calmodulin antagonists inhibit sea urchin sperm hyperpolarization necessary for directed movement toward the egg.
Proceedings of the Western Pharmacology Society·2012
Ganoderma lucidum reduces kainic acid-induced hippocampal neuronal damage via inflammatory cytokines and glial fibrillary acid protein expression.
Proceedings of the Western Pharmacology Society·2012
Effect of orlistat on lipid peroxidation, Na+, K+ ATPase, glutathione and serotonin in rat brain.
Proceedings of the Western Pharmacology Society·2012
Lactoferrin-Modified Ultra-Sustained Release Propofol Nanoparticles for Multi-Pathway Therapy of Depression via Intraperitoneal Injection.
International journal of nanomedicine·2026
Development of stereolithography 3D printed hollow vaginal devices with pore modulation to tailor the drug release.
International journal of pharmaceutics·2026